Mumbai | August 11, 2025 — Healthcare startup Truemeds has secured an $85 million (₹740 crore) Series C funding round, led by Accel and Peak XV Partners, with continued support from WestBridge Capital and Info Edge Ventures.
More Than Just Capital
Founded in 2019 by Akshat Nayyar and Dr. Kunal Wani, Truemeds uses proprietary algorithms to recommend affordable, clinically equivalent generic drugs helping patients save 50% to 70% on their monthly medicine bills.
The fresh capital will fuel:
- Expansion into non-metro markets through additional fulfillment centers
- Setup of a new tech hub in Bengaluru
- Recruitment of top tier engineering and product teams
- Initial rollout of diagnostic services alongside its core e-pharmacy offerings
Market Opportunity
India’s aging population and chronic disease burden make affordable access critical especially in smaller cities where medicine delivery is inconsistent. Truemeds’ model fills this gap.
This funding milestone reinforces the investor faith in deep-tech healthcare solutions aimed at affordability and accessibility especially when paired with disciplined execution. With the Series C round closing, Truemeds is poised to scale its vision of truly inclusive healthcare access.
Follow StartupStoryIndia for more founder driven narratives where purpose-led scale is changing India’s healthcare future.
